Christian shares his transformative journey from skepticism to advocacy for psilocybin, driven by compelling data on its therapeutic potential. He discusses his commitment to making these psychedelics accessible for those in need, highlighting his role in Atai Life Sciences as a major player in the biotech investment landscape. The conversation touches on the historical significance of psychedelics across cultures and their enduring effects on mental health.
